Similar articles

• Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.

  Rejnmark L, Vestergaard P, Mosekilde L. Rejnmark L, et al. J Hypertens. 2006 Mar;24(3):581-9. doi: 10.1097/01.hjh.0000203845.26690.cb. J Hypertens. 2006. PMID: 16467662 Clinical Trial.
• [So-called coronary drugs].

  Gamski M. Gamski M. Kardiol Pol. 1982;25(2):163-8. Kardiol Pol. 1982. PMID: 6125622 Review. Polish. No abstract available.
• [Treatment of migraine].

  Suomen Neurologinen yhdistys ry. Suomen Neurologinen yhdistys ry. Duodecim. 2002;118(11):1200-9. Duodecim. 2002. PMID: 12269238 Finnish. No abstract available.
• [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].

  Korovina EP. Korovina EP. Klin Med (Mosk). 1998;76(12):30-5. Klin Med (Mosk). 1998. PMID: 10067289 Clinical Trial. Russian.
• [The effects of antihypertensive drugs on lipid metabolism. Part I. Diuretics, beta-blockers, calcium antagonists].

  Martynov AI, Ostroumova OD, Mamaev VI, Rybkina TE, Kuznetsov VI, Tikhonova LIa, Smirnova MV. Martynov AI, et al. Klin Med (Mosk). 2001;79(8):8-12. Klin Med (Mosk). 2001. PMID: 11588795 Review. Russian. No abstract available.